🇺🇸 FDA
Patent

US 7238673

Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor

granted A61KA61K39/00A61K47/6957

Quick answer

US patent 7238673 (Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K39/00, A61K47/6957, A61K48/00, A61K9/0024